Correlation Between Champions Oncology and Janux Therapeutics
Can any of the company-specific risk be diversified away by investing in both Champions Oncology and Janux Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Champions Oncology and Janux Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Champions Oncology and Janux Therapeutics, you can compare the effects of market volatilities on Champions Oncology and Janux Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Champions Oncology with a short position of Janux Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Champions Oncology and Janux Therapeutics.
Diversification Opportunities for Champions Oncology and Janux Therapeutics
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Champions and Janux is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Champions Oncology and Janux Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Janux Therapeutics and Champions Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Champions Oncology are associated (or correlated) with Janux Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Janux Therapeutics has no effect on the direction of Champions Oncology i.e., Champions Oncology and Janux Therapeutics go up and down completely randomly.
Pair Corralation between Champions Oncology and Janux Therapeutics
Given the investment horizon of 90 days Champions Oncology is expected to generate 1.04 times more return on investment than Janux Therapeutics. However, Champions Oncology is 1.04 times more volatile than Janux Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Janux Therapeutics is currently generating about -0.02 per unit of risk. If you would invest 477.00 in Champions Oncology on August 31, 2024 and sell it today you would lose (25.00) from holding Champions Oncology or give up 5.24% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Champions Oncology vs. Janux Therapeutics
Performance |
| Timeline |
| Champions Oncology |
| Janux Therapeutics |
Champions Oncology and Janux Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Champions Oncology and Janux Therapeutics
The main advantage of trading using opposite Champions Oncology and Janux Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Champions Oncology position performs unexpectedly, Janux Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Janux Therapeutics will offset losses from the drop in Janux Therapeutics' long position.| Champions Oncology vs. Molecular Partners AG | Champions Oncology vs. MediciNova | Champions Oncology vs. Anebulo Pharmaceuticals | Champions Oncology vs. Shattuck Labs |
| Janux Therapeutics vs. Mineralys Therapeutics, Common | Janux Therapeutics vs. Eliem Therapeutics | Janux Therapeutics vs. Anebulo Pharmaceuticals | Janux Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |